![Eyal Attar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Eyal C.
Attar formerly worked at Agios Pharmaceuticals, Inc., as Senior Medical Director from 2016 to 2019, Harvard Medical School, as Member-Leukemia Center, Aprea Therapeutics, Inc., as Chief Medical Officer & Senior Vice President, and Vor Biopharma, Inc., as Chief Medical Officer from 2022 to 2025.
Dr. Attar received his doctorate degree from UNC School of Medicine.
Eerdere bekende functies van Eyal Attar
| Bedrijven | Functie | Einde |
|---|---|---|
| VOR BIOPHARMA INC. | Hoofd Techniek/Wetenschap/O&O | 18-04-2025 |
| AGIOS PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2019 |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| APREA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Eyal Attar
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
45
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UNC School of Medicine
 UNC School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vor Biopharma, Inc.
 Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
Aprea Therapeutics, Inc.
 Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
